NASDAQ:CSBR

Champions Oncology Stock Insider Trading

etoro logo Buy CSBR
*Your capital is at risk
$5.69
-0.0350 (-0.611%)
At Close: Jun 03, 2026

Champions Oncology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 2.8M and sold 8.3K CSBR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 2.8M shares
Sell 8.3K shares
98% Buy Activity
Weak Negative Correlation
Buy Signal High Confidence
May 26, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 100.
  • Confidence increased due to high data reliability score of 90.
  • Supported by overwhelming buy-side pressure (98% buys).

Historical Insider Trades

Date Type Person Role Amount
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Breitfeld Philip P.
Director
Director 18 715
Value: $86.8K
Oct 31, 2024
Buy
Common Stock
M-Exempt
Ackerman Joel
Director
Director 16 667
Value: $90.5K
Oct 31, 2024
Buy
Common Stock
M-Exempt
Ackerman Joel
Director
Director 88 470
Value: $185.8K
Oct 31, 2024
Buy
Option to purchase Common Stock
M-Exempt
Ackerman Joel
Director
Director 88 470
Value: $185.8K
Oct 31, 2024
Buy
Option to purchase Common Stock
M-Exempt
Ackerman Joel
Director
Director 16 667
Value: $90.5K
Oct 31, 2024
Buy
Option to purchase Common Stock
M-Exempt
Ackerman Joel
Director
Director 16 667
Value: $90.5K
Oct 31, 2024
Buy
Option to purchase Common Stock
M-Exempt
Ackerman Joel
Director
Director 88 470
Value: $185.8K
Oct 31, 2024
Buy
Common Stock
M-Exempt
Ackerman Joel
Director
Director 88 470
Value: $185.8K
Oct 31, 2024
Buy
Common Stock
M-Exempt
Ackerman Joel
Director
Director 16 667
Value: $90.5K
Jan 12, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 1 000
Value: $7K
Jan 12, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 1 000
Value: $7K
Jan 11, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 2 000
Value: $12.5K
Jan 11, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 2 000
Value: $12.5K
Jan 10, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 2 944
Value: $18.6K
Jan 10, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 2 944
Value: $18.6K
Jan 09, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 3 000
Value: $18.8K
Jan 09, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 3 000
Value: $18.8K
Jan 08, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 1 000
Value: $6K
Jan 08, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 1 000
Value: $6K
Jan 05, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 2 000
Value: $12.2K
Jan 05, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 2 000
Value: $12.2K
Jan 04, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 3 000
Value: $18.4K
Jan 04, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 3 000
Value: $18.4K
Jan 03, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 500
Value: $3K
Jan 03, 2024
Buy
Common Stock
P-Purchase
Mendelson Daniel Newman
Director
Director 500
Value: $3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CHAMPIONS ONCOLOGY
Champions Oncology
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE